Sebastian Szmit, Consultant at the Maria Sklodowska-Curie National Research Institute of Oncology, shared an article by Eva Kempers et al. on LinkedIn:
“Next great study published by the research group associated with the SERENITY trial supported by European Commission.
I am proud to be part of this scientific adventure!”
Discontinuation of anticoagulants and occurrence of bleeding and thromboembolic events in vitamin K antagonist users with a life-limiting disease.
Authors: Eva Kempers, et al.
